GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » Price-to-Free-Cash-Flow

Aadi Bioscience (FRA:3350) Price-to-Free-Cash-Flow : N/A (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience Price-to-Free-Cash-Flow?

As of today (2024-06-06), Aadi Bioscience's share price is €1.59. Aadi Bioscience's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.10. Hence, Aadi Bioscience's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Aadi Bioscience's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 4 years, Aadi Bioscience's highest Price-to-Free-Cash-Flow Ratio was 161.73. The lowest was 140.05. And the median was 145.36.

FRA:3350's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.425
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Aadi Bioscience's Free Cash Flow per Share for the three months ended in Mar. 2024 was €-0.70. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €-2.10.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -57.10% per year.

During the past 4 years, Aadi Bioscience's highest 3-Year average Free Cash Flow per Share Growth Rate was -57.10% per year. The lowest was -57.10% per year. And the median was -57.10% per year.


Aadi Bioscience Price-to-Free-Cash-Flow Historical Data

The historical data trend for Aadi Bioscience's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience Price-to-Free-Cash-Flow Chart

Aadi Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
- - - -

Aadi Bioscience Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aadi Bioscience's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Aadi Bioscience's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aadi Bioscience's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aadi Bioscience's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aadi Bioscience's Price-to-Free-Cash-Flow falls into.



Aadi Bioscience Price-to-Free-Cash-Flow Calculation

Aadi Bioscience's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1.59/-2.104
=N/A

Aadi Bioscience's Share Price of today is €1.59.
Aadi Bioscience's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.10.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Aadi Bioscience  (FRA:3350) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Aadi Bioscience Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Aadi Bioscience (FRA:3350) Business Description

Traded in Other Exchanges
Address
17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (FRA:3350) Headlines

No Headlines